CORRIGENDUM: Impact of the Covid-19 Pandemic on the Diagnosis of Tuberculosis in Brazil: Is the Who End Tb Strategy at Risk?(Front. Pharmacol., (2022), 13, (891711), 10.3389/Fphar.2022.891711)

AuthID
 P-00X-904
11
Author(s)
Silva da Paz, W
·
dos Santos Sales, VB
·
Hilario de Jesus, GF
·
dos Santos Tavares, D
·
Lopes Sousa, AF
·
Vieira de Melo, E
·
Feliciano do Carmo, R
·
Freire de Souza, CD
·
Bezerra Santos, M
Tipo de Documento
Correction
Year published
2022
Publicado
in Frontiers in Pharmacology, ISSN: 1663-9812
Volume: 13
Indexing
Scopus®
Google Scholar®
Publication Identifiers
SCOPUS: 2-s2.0-85138325377
Source Identifiers
ISSN: 1663-9812
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service